Aluf Holdings Inc. to Begin Development of Digital Healthcare Device
Aluf Holdings, Inc. (OTC PINK: AHIX) has announced its plans to develop digital healthcare devices in collaboration with SBN Group Corp. This initiative aims to enhance the quality of life for individuals with chronic medical issues. The global digital health market is projected to grow from $220 million in 2021 to $551 million by 2027, indicating a CAGR of 16.5%. CEO Sam M. Jakobs emphasizes the importance of expanding healthcare solutions for an aging demographic. Aluf Holdings focuses on next-gen technology, including biometrics and cybersecurity.
- Collaboration with SBN Group Corp. to develop digital healthcare devices.
- Entrance into a growing market projected to reach $551 million by 2027.
- Focus on improving quality of life for aging individuals and those with chronic illnesses.
- None.
FT. LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Aluf Holdings, Inc. ("AHIX") ("Aluf") (OTC PINK: AHIX), a holding company headquartered in Fort Lauderdale, FL, engaged in acquiring, operating, and managing subsidiaries in the development and sale of proprietary software, bringing to market advanced technologies and business management solutions, announced today their plans in the development of digital healthcare devices. The development of the device is in collaboration with SBN Group Corp., a New York based healthcare solutions company focused on tailoring healthcare solutions for individuals, corporate clients, and healthcare providers. The primary goal of the device is to optimize the patient’s standard of living while maintaining independence, privacy, and safety.
“According to SkyQuest Technology Consulting, the global digital health market is projected to reach
About Aluf Holdings, Inc.:
Aluf Holdings, Inc. is a publicly traded holding company whose core competency is to acquire, manage and propel "Next Gen" technology companies into the future. Our focus includes Biometrics, Cybersecurity, Computer Vision, and Software/Hardware verticals.
For more information go to www.aluf.com
Safe Harbor Statement:
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E and/or 27E of the Securities Exchange Act of 1934 that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company and the risks and uncertainties detailed from time to time in reports filed by the company with the Securities and Exchange Commission. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, the company's ability to raise necessary financing, retention of key personnel, timely delivery of inventory from the company's suppliers, timely product development, product acceptance, and the impact of competitive services and products, in addition to general economic risks and uncertainties.
Corporate Contact:
Aluf Holdings, Inc.
Teresa McWilliams
Chief Financial Officer
866-793-1110
FAQ
What are Aluf Holdings' plans for digital healthcare devices?
What is the projected growth of the digital health market?
What is the stock symbol of Aluf Holdings?
Who is the CEO of Aluf Holdings?
What is the focus of Aluf Holdings?
